Division of Brain Sciences, Charing Cross Hospital, Imperial College London, Fulham Palace Road, London, W6 8RF, UK.
Curr Neurol Neurosci Rep. 2017 Nov 2;17(12):98. doi: 10.1007/s11910-017-0807-1.
The purpose of this review was to review the imaging, particularly positron emission tomography (PET), findings in neurorestoration studies in movement disorders, with specific focus on neural transplantation in Parkinson's disease (PD) and Huntington's disease (HD).
PET findings in PD transplantation studies have shown that graft survival as reflected by increases in dopaminergic PET markers does not necessarily correlate with clinical improvement. PD patients with more denervated ventral striatum and more imbalanced serotonin-to-dopamine ratio in the grafted neurons tended to have worse outcome. In HD transplantation studies, variable graft survival and clinical responses may be related to host inflammatory/immune responses to the grafts. Information gleaned from imaging findings in previous neural transplantation studies has been used to refine study protocol and patient selection in future trials. This includes identifying suitable candidates for transplantation using imaging markers, employing multiple and/or novel PET tracers to better assess graft functions and inflammatory responses to grafts.
本文旨在回顾运动障碍神经修复研究中的影像学表现,特别是正电子发射断层扫描(PET),重点关注帕金森病(PD)和亨廷顿病(HD)中的神经移植。
PD 移植研究的 PET 结果表明,移植后多巴胺能 PET 标志物的增加所反映的移植物存活并不一定与临床改善相关。移植神经元中腹侧纹状体去神经支配程度更高且 5-羟色胺与多巴胺比值更失衡的 PD 患者往往预后更差。在 HD 移植研究中,移植物存活和临床反应的差异可能与宿主对移植物的炎症/免疫反应有关。从以前的神经移植研究的影像学发现中获得的信息已被用于改进未来试验的研究方案和患者选择。这包括使用影像学标志物来识别适合移植的候选者,采用多种和/或新型 PET 示踪剂来更好地评估移植物的功能和对移植物的炎症反应。